tas-102 in refractory metastatic colorectal cancer
Published 9 years ago • 766 plays • Length 4:58Download video MP4
Download video MP3
Similar videos
-
6:43
tas-102 in metastatic colorectal cancer
-
4:19
the role of tas-102 in metastatic colorectal cancer
-
3:39
impact of tas-102 in metastatic colorectal cancer - video abstract id 113320
-
5:42
role of tas-102 (trifluridine/tipiracil) in advanced colorectal cancer
-
4:54
the first oral fluoropyrimidine for mcrc—tas-102
-
1:12
dr. lenz on choosing between regorafenib and tas-102 in crc
-
1:28
dr. overman on distinctions between regorafenib and tas-102 in crc
-
2:49
management of side effects with tas-102
-
0:49
dr. yoshino on u3-1565 and tas-102 in colorectal cancer
-
7:11
novel agents in the metastatic colorectal cancer refractory setting
-
1:16
dr. eng on roles of regorafenib and tas-102 in crc treatment
-
3:53
when you have decided to prescribe trifluridine/tipiracil
-
2:54
safety of tas-102 in patients with metastatic gastric/ge junction and colorectal cancer
-
7:54
regorafenib vs tas-102 salvage therapy
-
2:24
dr. bekaii saab compares toxicities of regorafenib and tas-102 in colorectal cancer
-
1:35
dr. lockhart on next steps for regorafenib and tas-102 in mcrc
-
0:50
dr. wu on possible combinations with tas-102 in crc
-
4:30
trifluridine/tipiracil in advanced colorectal cancer
-
1:39
dr. hochster on the safety analysis of tas-102 in crc and gastric/gej cancer